Cardiovascular aspects and the state of vegetative balance in patients with arterial hypertension associated with dyslipidemia

Cardiovascular aspects and the state of vegetative balance in patients with arterial hypertension associated with dyslipidemia

Objective. The aim of this study was to investigate the effect of dyslipidemia on cerebral and intra-cardiac hemodynamics, heart and blood vessels remodeling and the state of vegetative balance in patients with hypertension. Materials and Methods. 100 patients with stage II arterial hypertension...

Full description

Bibliographic Details
Main Author:	O. V. Vizir-Tronova
Format:	Article
Language:	English
Published:	Zaporozhye State Medical University 2017-10-01
Series:	Zaporožskij Medicinskij Žurnal
Subjects:	hypertension blood pressure cardiac remodeling autonomic regulation dyslipidemia
Online Access:	http://zmj.zsmu.edu.ua/article/view/110083/107056

Similar Items

The contribution of modifiable risk factors to the formation of cardiovascular remodelling and vegetative balance in patients with essential hypertension
by: V. V. Syvolap, et al.
Published: (2017-12-01)

Influence of additional risk factors on the antihypertensive efficacy of eprosartan and telmisartan in patients with essential hypertension
by: V. V. Syvolap, et al.
Published: (2017-12-01)

The impact of obesity on the parameters of cardiovascular remodeling, cerebral blood flow and autonomic regulation of cardiac rhythm in hypertensive patients
by: V. V. Syvolap, et al.
Published: (2017-04-01)

FLUVASTATIN EFFECTS ON BLOOD CELL AGGREGATION IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2013-04-01)

Vascular control over blood cells aggregation in patients with arterial hypertension with dyslipidemia
by: I. N. Medvedev, et al.
Published: (2016-02-01)

The relationship between drug therapy adherence and the results of blood pressure targets achievement in hypertensive patients with dyslipidemia complications at Government Hospital in Yogyakarta
by: Andriana Sari, et al.
Published: (2020-11-01)

Associations of dipping and non-dipping hypertension with cardiovascular diseases in patients with dyslipidemia
by: Siping Dai, et al.
Published: (2018-01-01)

Practical solutions for hypertensive patients with dyslipidemia☆
by: Charalambos Vlachopoulos, et al.
Published: (2017-04-01)

PLATELET HEMOSTASIS DYNAMICS IN SIMVASTATINTREATED PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2010-02-01)

Pleiotropic Effects of Losartan in Hypertensive Patients with Dyslipidemia
by: Sivakumar Sivasubramaniam, et al.
Published: (2017-09-01)

Blood pressure and low-density lipoprotein cholesterol control status in Chinese hypertensive dyslipidemia patients during lipid-lowering therapy
by: Xiaowei Yan, et al.
Published: (2019-01-01)

Rosuvastatin microcirculatory effects in patients with dyslipidemia and arterial hypertension
by: D. V. Nebieridze, et al.
Published: (2006-08-01)

Cardiovascular remodeling and calcium-regulating function of parathyroid glands in arterial hypertension
by: B. G. Iskenderov, et al.
Published: (2007-04-01)

PRAVASTATIN IN CORRECTION OF VESSEL WALL ANTIPLATELET CONTROL OVER THE BLOOD CELLS IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2014-12-01)

Dyslipidemia and Associated Risk Factors among Nigerians with Hypertension
by: Olufisayo Gabriel Ayoade, et al.
Published: (2020-08-01)

Assessment of blood pressure control in adult hypertensive patients in eastern Sudan
by: Saeed M. Omar, et al.
Published: (2018-02-01)

Association between Cardiac Remodeling and Metabolic Alteration in an Experimental Model of Obesity Induced by Western Diet
by: Artur Junio Togneri Ferron, et al.
Published: (2018-11-01)

LIPITENSION : Interplay between dyslipidemia and hypertension
by: Jamshed J Dalal, et al.
Published: (2012-01-01)

Role of dyslipidemia in the development of early-onset preeclampsia
by: Thabat J Al-Maiahy, et al.
Published: (2021-01-01)

Left ventricular geometric sportsmen power sports heavyweight with arterial hypertension
by: Alexander B. Miroshnikov, et al.
Published: (2020-09-01)

Efficacy and Safety of a Single-Pill Combination of Atorvastatin/Amlodipine in Patients with Arterial Hypertension and Dyslipidemia
by: Stefan Naydenov Naydenov, et al.
Published: (2018-01-01)

Nutrients Intake in Individuals with Hypertension, Dyslipidemia, and Diabetes: An Italian Survey
by: Cecilia Guastadisegni, et al.
Published: (2020-03-01)

Arterial hypertension and dyslipidemia in a HIV-positive patient treated with antiretroviral therapy
by: Alessandro Maloberti, et al.
Published: (2012-03-01)

Effects of fluvastatin, valsartan, and their combination on endothelial function in patients with arterial hypertension and dyslipidemia
by: T. Sh. Mirilashvili, et al.
Published: (2009-08-01)

Identification of susceptibility loci for cardiovascular disease in adults with hypertension, diabetes, and dyslipidemia
by: Youhyun Song, et al.
Published: (2021-02-01)

TREATMENT OF ARTERIAL HYPERTENSION AND DYSLIPIDEMIA IN REAL CLINICAL PRACTICE. THE SYNERGY STUDY. Part 2
by: O. M. Drapkina, et al.
Published: (2017-07-01)

MICRORHEOLOGY OF ERYTHROCYTES IN ARTERIAL HYPERTENSION AND DYSLIPIDEMIA WITH A COMPLEX HYPOLIPIDEMIC TREATMENT
by: I. N. Medvedev
Published: (2017-05-01)

Item condition of the autonomic nervous system in patients with hypertension stage II low additional cardiovascular risk depending on the status of smokers
by: E. A. Poznanskaya, et al.
Published: (2013-12-01)

Self-reported hypertension, dyslipidemia and hyperuricemia management by Italian Internal Medicine Units: a national survey of the FADOI Study Group in Cardiovascular Medicine
by: Alberto Mazza, et al.
Published: (2017-11-01)

AGGREGATION PROPERTIES OF BLOOD CELLS AND VASCULAR CONTROL OVER THEM IN PATIENTS WITH ARTERIAL HYPERTENSION AND DYSLIPIDEMIA
by: I. N. Medvedev, et al.
Published: (2015-04-01)

Closed-Loop Cardiovascular Interactions and the Baroreflex Cardiac Arm: Modulations Over the 24 h and the Effect of Hypertension
by: Gianfranco Parati, et al.
Published: (2019-05-01)

ADVANTAGES AND NOVELTY OF CLINICAL APPLICATION OF THE TRIPLE COMBINATION FOR ARTERIAL HYPERTENSION WITH DYSLIPIDEMIA: ACE INHIBITOR PERINDOPRIL WITH ROSUVASTATIN AND INDAPAMIDE
by: M. L. Maksimov, et al.
Published: (2017-08-01)

ESSENTIAL ARTERIAL HYPERTENSION AND RISK FACTORS ASSOCIATED WITH HYPERTENSIVE NEPHROPATHY
by: Boban Milojković, et al.
Published: (2014-12-01)

Alteraciones lipídicas en la hipertensión arterial esencial
by: René LLapur Milián, et al.

Study of pattern of dyslipidemia and its correlation with cardiovascular risk factors in patients with proven coronary artery disease
by: Namita Mahalle, et al.
Published: (2014-01-01)

USING A COMBINATION OF PERINDOPRIL, INDAPAMIDE AND ROSUVASTATIN IN THE TREATMENT OF PATIENTS WITH HYPERTENSION AND DYSLIPIDEMIA
by: O. M. Drapkina, et al.
Published: (2017-09-01)

The profile of hypertension and dyslipidemia in prediabetic subjects; results of the Isfahan Diabetes Prevention program: A large population-based study
by: Bijan Iraj, et al.
Published: (2015-01-01)

The Associations between Liver Enzymes and Cardiovascular Risk Factors in Adults with Mild Dyslipidemia
by: Eun-Ock Park, et al.
Published: (2020-04-01)

Independent Effects of Hypertension and Obesity on Left Ventricular Mass and Geometry: Evidence from the Cardiovision 2030 Study
by: Andrea Maugeri, et al.
Published: (2019-03-01)

Blood pressure, dyslipidemia and inflammatory factors are related to body mass index in scholar adolescents
by: Hanane Ghomari-Boukhatem, et al.
Published: (2016-12-01)